Table 3. Disease modifying treatments received for at least 3 months.

IM: immunomodulatory disease modifying treatments; IS: Immunosuppressant disease modifying treatments. The total is above 100% as many patients have received more than one DMT during the time course of their disease.

	% (n)
IM     ▪ Interferon beta     ▪ Glatiramer Acetate     ▪ Dimethyl fumarate	64.6 (703) ▪ 52.5 (572) ▪ 23.0 (250) ▪ 0.2 (2)
IS     ▪ Fingolimod     ▪ Natalizumab     ▪ Mitoxantrone     ▪ Methotrexate     ▪ Azathioprine     ▪ Cyclophosphamide     ▪ Mycophenolate Mofetil     ▪ Teriflunomide     ▪ Rituximab	31.8 (346) ▪ 4.3 (47) ▪ 10.2 (111) ▪ 4.0 (44) ▪ 9.6 (104) ▪ 5.1 (55) ▪ 4.3 (47) ▪ 3.4 (37) ▪ 0.1 (1) ▪ 0.1 (1)
None	24.8 (270)